GMO GOLDEN RICE TRIALS FAIL
The troubled project to develop GMO 'golden rice' cultivars has just hit a serious obstacle. An attempt to breed the 'event' responsible for carotenoid production into a commercial rice variety has produced widespread genomic instability, causing weak plants and poor grain production. Has the golden rice hype bubble finally burst?
A new study reports unintended effects in GM golden rice, which is engineered to produce precursors of vitamin A called carotenoids.
Crossing the GM rice with the Indian variety Swarna, a step necessary for commercialization, led to a nasty surprise.
The resulting plants were stunted, showed extensive abnormalities in their growth, and had reduced grain yield, as compared with the non-GM Swarna variety.
The researchers identified several reasons for the unexpected effects, all indicative of genomic instability in offspring plants resulting from 'breeding out' the parent golden rice with non-GMO in-field cultivars.
First, the new gene constructs interfered with the plant's own gene for producing growth hormones. Second, the additional gene constructs were not, as intended, active solely in the kernels, but also in the leaves. This led to a substantial reduction in the content of the chlorophyll that provides the plants with energy from sunlight.
The reduction in chlorophyll may be to blame for the plants' stunted growth and poor grain yields. And most worrying for the developers, the chlorophyll deficit appears to result from a deep, systemic problem with the primary GE 'event' on which the entire golden rice project depends.
These unintended effects were not detected in previous investigations, and it was assumed that the genetically engineered plants used in these trials would show genetic stability. In fact, these detrimental genomic effects remained undetected until the transgenic plants were crossed with the variety called Swarna, which is grown widely in India.
"Then they could potentially have avoided this negative outcome at such a late stage in the development and release of golden rice. Now it's back to square one, with years of research work and millions of dollars wasted."
The authors of the study conclude: " ... we discovered that the insertion of transgene for pro-vitamin A trait in the donor GR2-R1 event in Kaybonnet, had disrupted a native OsAux1 gene, which resulted in phenotypic abnormality and poor agronomic performance of the backcross derived Golden Swarna lines, making them unfit for commercial cultivation inspite of having high provitamin A content.
"The study conclusively demonstrates the importance of event characterization and event selection before adopting the transgenic germplasm into introgression breeding."
Failed golden rice could endanger whole rice harvest
The new findings are highly relevant for the risk assessment of the plants. Once released, the transgenic plants could spread their gene constructs into populations of weedy rice as well as other cultivated varieties.
In addition, genomic effects not found in the original plants can occur in plant offspring. At the stage when the hazards are identified, it can be impossible to remove the transgenes from the environment.
'Years of misplaced hype'
GM golden rice is much hyped by GMO proponents as a triumph of GM that will save people in the Third World from nutritional deficiencies and vitamin A deficiency-related blindness. The new study casts doubt on the viability of the golden rice project, which has produced nothing of value despite years of misplaced hype.
In contrast, common-sense approaches to combating vitamin A deficiency are working in the Philippines, the country targeted for GMO golden rice release – they just need to be rolled out more widely. – Third World Network Features.
The above article is reproduced from The Ecologist. 1 March 2017. It was originally published by GMWatch. This version includes some edits and additions by The Ecologist.